Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.57 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.57 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.57 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | HPGD | P15428 | 2/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.48 |
| ▸ | GAA | P10253 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.48 |
| ▸ | HPRT1 | P00492 | 2/20 | 0.47 |
| ▸ | HTR2A | P28223 | 1/20 | 0.45 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.41 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.41 |
| ▸ | GLA | P06280 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29625674 | 1.00 | HSD17B10 (0.57) | HSD17B10CYP1A2CYP2C9CYP2C19ALDH1A1 | |
| SCHEMBL29625694 | 0.89 | HSD17B10 (0.79) | HSD17B10CYP1A2CYP2C9CYP2C19ALDH1A1 | |
| SCHEMBL23515204 | 0.89 | HSD17B10 (0.79) | HSD17B10CYP1A2CYP2C9CYP2C19ALDH1A1 | |
| SCHEMBL4931272 | 0.88 | HSD17B10 (0.46) | HSD17B10CYP1A2CYP2C9CYP2C19ALDH1A1 | |
| SCHEMBL10751032 | 0.84 | ALDH1A1 (0.62) | HSD17B10CYP1A2CYP2C9CYP2C19ALDH1A1 | |
| SCHEMBL23515356 | 0.84 | IDO1 (0.51) | HPGDKDM4EMAPTPOLB | |
| SCHEMBL29625649 | 0.84 | IDO1 (0.51) | HPGDKDM4EMAPTPOLB | |
| SCHEMBL11842789 | 0.83 | HSD17B10 (0.46) | HSD17B10CYP1A2CYP2C9CYP2C19ALDH1A1 | |
| SCHEMBL1161044 | 0.83 | ALDH1A1 (0.46) | HSD17B10CYP1A2CYP2C9CYP2C19ALDH1A1 | |
| SCHEMBL11841719 | 0.83 | ALDH1A1 (0.50) | HSD17B10CYP1A2CYP2C9CYP2C19ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230015875-A1 | Ion Channel Antagonists/Blockers and Uses Thereof | SHANGHAI EAST HOSPITAL (CN) | 2023-01-19 | — | — | US | disclosed |
| US-5362822-A | Epoxy resin for polyurethane having enhanced mechanical properties | THE DOW CHEMICAL COMPANY (US) | 1994-11-08 | — | — | US | disclosed |
| EP-0568908-A2 | Polyvalent epoxy compounds | BASF Lacke + Farben AG (DE) | 1993-11-10 | — | — | EP | disclosed |
| US-5189117-A | Tensile strength, tear strength, waterproofing | THE DOW CHEMICAL COMPANY (US) | 1993-02-23 | — | — | US | disclosed |
| US-4792404-A | USING CHLORINE-RESISTANT POLYAMIDE MEMBRANE | ALLIED-SIGNAL INC. (US) | 1988-12-20 | — | — | US | disclosed |
| US-4699933-A | Polyurethanes containing triazine or both triazine and oxazoline, triazine and imino carbamate or triazine and other N-heterocyclic groups | THE DOW CHEMICAL COMPANY (US) | 1987-10-13 | — | — | US | disclosed |
| US-4555553-A | HIGH STRENGTH; HEAT RESISTANCE | THE DOW CHEMICAL COMPANY (US) | 1985-11-26 | — | — | US | disclosed |
| US-4555554-A | FROM EPOXY RESIN AND MONOUNSATURATED MONOCAR-BOXYLIC ACID | THE DOW CHEMICAL COMPANY (US) | 1985-11-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230015875-A1 | Ion Channel Antagonists/Blockers and Uses Thereof | CACNA1F, CACNA1S, CACNA1D | HSD17B10 1342/4885CYP1A2 955/4885CYP2C9 879/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.